Qualitatively, the patients (mean age 73.5 years) readily accepted the telemedicine with their GP.  They viewed it as up-to-date, inovative and advantageous for future generations.  Nine out of 10 patients showed a reduction in the systolic blood pressure and 7 out of 10 showed a decrease in weight over the first 60 days of telemonitoring.  In addition, the 'quality of life' scores of the Telemedicine group appeared to significantly increase in contrast to the control group whose scores deteriorated.  The technique seems robust and reliable, and the result clearly shows a clinical benefit.